Go to the profile of Microquin

Microquin

 

About Microquin

Founded in London (United Kingdom) in 2016, MicroQuin was born out of a collaborative and inclusive approach to research. MicroQuin is a biotechnology, R&D based company currently focusing on developing therapeutics to address a range of oncological disease. MicroQuin is progressing lead compounds into clinical trials, which offer a potential cure to Breast Cancer and other diseases.

Therapeutic Areas

Autoimmune disorders Oncology

Technologies

Drug delivery Peptides Other

Company Type

Biotechnology – R&D services

State of Ownership

Private

Sponsorship Group

Networker

Topics

Topics contributed to:

Oncology

Editions participated in:

September 2017